 您的位置：对照品 > 标准品 > 欧洲药典标准品 > |
|
|
|
| 产品基本信息 |
|
| 产品编号：B287633 |
| 产品名称：N-4-Benzyloxyphenyl α-Benzilidene-d5 Isobutyrylacetamide |
| 产品CAS：1020719-20-3 |
| 规格含量：50mg |
| 产品价格：面议 |
| 联系我们: |
 |
|
 |
|
|
| 产品详细介绍 |
| 标准品编号: |
B287633 |
| 名称: |
N-4-Benzyloxyphenyl α-Benzilidene-d5 Isobutyrylacetamide |
| 别名: |
4-Methyl-3-oxo-N-[4-(phenylmethoxy)phenyl]-2-(phenyl-2,3,4,5,6-d5-methylene)pentanamimde; |
| CAS号: |
1020719-20-3 |
| 备用CAS: |
163217-66-1 unlabelled |
| 分子式: |
C₂₆H₂₀D₅NO₃ |
| 外观： |
白色固体 |
| 分子量: |
404.51 |
| 溶解度: |
Acetone, Chloroform, Dichloromethane, Ethyl Acetate |
| 类别: |
Building Blocks; Isotopic Labeled Analogues; |
| 应用: |
A deuterated intermediate of the metabolite of Atorvastin, a selective, competitive HMG-CoA reductase inhibitor. Atorvastin is the only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia. |
| 文献 |
|
|
|
|
|
|
